WPI 1119 (Mirtazapine 45 mg)
Pill imprint WPI 1119 has been identified as Mirtazapine 45 mg.
Mirtazapine is used in the treatment of major depressive disorder; insomnia; anxiety; depression; post traumatic stress disorder (and more), and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy. Mirtazapine 45 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 45 mg
- 16.00 mm
- Elliptical / Oval
- Prescription only
hypromellose 2910 (3 mPa.s)
hypromellose 2910 (6 mPa.s)
polyethylene glycol 400
|NDC Code||Manufacturer / Repackager|
|16590-0155||Stat RX USA LLC (repackager)|
|58016-0282||Southwood Pharmaceuticals Inc (repackager)|
|63874-1155||Altura Pharmaceuticals Inc (repackager)|
|68258-7006||Dispensing Solutions Inc. (repackager)|
Note: Inactive ingredients may vary.
More about mirtazapine
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.